These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 3503554
1. Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population. Andress DL, Maloney NA, Endres DB, Sherrard DJ. J Bone Miner Res; 1986 Oct; 1(5):391-8. PubMed ID: 3503554 [Abstract] [Full Text] [Related]
2. Evidence for a toxic effect of aluminum on osteoblasts: a histomorphometric study in hemodialysis patients with aplastic bone disease. Parisien M, Charhon SA, Arlot M, Mainetti E, Chavassieux P, Chapuy MC, Meunier PJ. J Bone Miner Res; 1988 Jun; 3(3):259-67. PubMed ID: 3213621 [Abstract] [Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
4. Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication. Charhon SA, Chavassieux PM, Chapuy MC, Boivin GY, Meunier PJ. J Lab Clin Med; 1985 Aug; 106(2):123-31. PubMed ID: 2410522 [Abstract] [Full Text] [Related]
5. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients. Ureña P, Ferreira A, Kung VT, Morieux C, Simon P, Ang KS, Souberbielle JC, Segre GV, Drüeke TB, De Vernejoul MC. J Bone Miner Res; 1995 Jun; 10(6):932-9. PubMed ID: 7572317 [Abstract] [Full Text] [Related]
6. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination. Dunstan CR, Hills E, Norman AW, Bishop JE, Mayer E, Wong SY, Eade Y, Johnson JR, George CR, Collett P. Miner Electrolyte Metab; 1985 Jun; 11(6):358-68. PubMed ID: 3877862 [Abstract] [Full Text] [Related]
7. Calcitropic hormonal status in north Indian patients with end-stage renal disease. Singh AK, Avula S, Kher V, Rao DS, Mithal A. Natl Med J India; 1999 Jun; 12(5):202-7. PubMed ID: 10612998 [Abstract] [Full Text] [Related]
9. Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure. Andress DL, Ott SM, Maloney NA, Sherrard DJ. N Engl J Med; 1985 Feb 21; 312(8):468-73. PubMed ID: 3969109 [Abstract] [Full Text] [Related]
10. Silent and progressing accumulation of aluminum in bone without definite histological osteomalacic aspects in chronic hemodialysis patients. Suzuki M, Hirasawa Y, Tanizawa T. Clin Nephrol; 1995 Nov 21; 44 Suppl 1():S51-5. PubMed ID: 8608664 [Abstract] [Full Text] [Related]
11. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment. Coen G, Mazzaferro S, Costantini S, Ballanti P, Carrieri MP, Giordano R, Smacchi A, Sardella D, Bonucci E, Taggi F. Miner Electrolyte Metab; 1989 Nov 21; 15(5):295-302. PubMed ID: 2811788 [Abstract] [Full Text] [Related]
14. Histomorphometric evidence of deleterious effect of aluminum on osteoblasts. de Vernejoul MC, Belenguer R, Halkidou H, Buisine A, Bielakoff J, Miravet L. Bone; 1985 Nov 21; 6(1):15-20. PubMed ID: 2581595 [Abstract] [Full Text] [Related]
16. The evolution of osteomalacia in the rat with acute aluminum toxicity. Rodriguez M, Felsenfeld AJ, Llach F. J Bone Miner Res; 1989 Oct 21; 4(5):687-96. PubMed ID: 2816514 [Abstract] [Full Text] [Related]
17. Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hemofiltration. Sebert JL, Fournier A, Leflon P, Fohrer P, de Frémont JF, Morinière P, Galy C, Marie A, Demontis R, Boudailliez B. Nephron; 1986 Oct 21; 42(1):34-40. PubMed ID: 3941748 [Abstract] [Full Text] [Related]